Yayın:
Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: A real-life evidence from biostar nationwide registry

dc.contributor.authorDuruöz, Mehmet Tuncay
dc.contributor.authorAtaman, Şebnem
dc.contributor.authorBodur, Hatice
dc.contributor.authorÇay, Hasan Fatih
dc.contributor.authorMelikoğlu, Meltem Alkan
dc.contributor.authorAkgül, Özgür
dc.contributor.authorÇapkın, Erhan
dc.contributor.authorGürer, Gülcan
dc.contributor.authorÇevik, Remzi
dc.contributor.authorGoegues, Feride Nur
dc.contributor.authorKamanlı, Ayhan
dc.contributor.authorYurdakul, Fatma
dc.contributor.authorYağcı, İlker
dc.contributor.authorRezvani, Aylin
dc.contributor.buuauthorAltan, Lale
dc.contributor.buuauthorALTAN İNCEOĞLU, LALE
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentFizik Tedavi ve Rehabilitasyon Ana Bilim Dalı
dc.contributor.researcheridJWQ-3548-2024
dc.date.accessioned2024-11-29T06:12:13Z
dc.date.available2024-11-29T06:12:13Z
dc.date.issued2023-12-29
dc.description.abstractPatients with rheumatoid arthritis (RA) have increased morbidity and mortality due to cardiovascular (CV) comorbidities. The association of CV diseases (CVD) and traditional CV risk factors has been debated, depending on patient and RA characteristics. This study aimed to find the prevalence of CVD and CV risk factors in patients with RA. A multi-center cross-sectional study was performed on RA patients using the BioSTAR (Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Registry) in September 2022. Socio-demographic, clinical, and follow-up data were collected. Myocardial infarction, ischemic heart disease, peripheral vascular disorders, congestive heart failure, ischemic stroke, and transient ischemic attack were regarded as major adverse cardiovascular events (MACEs). CVD was defined as the presence of at least one clinical situation of MACE. Group 1 and Group 2 included patients with and without CVD. Prevalence rates of CVD and traditional CV risk factors were the primary outcomes. Secondary outcomes were the differences in the clinical characteristics between patients with and without CVD. An analysis of 724 patients with a mean age of 55.1 +/- 12.8 years diagnosed with RA was conducted. There was a female preponderance (79.6%). The prevalence rate of CVD was 4.6% (n = 33). The frequencies of the diseases in the MACE category were ischemic heart disease in 27, congestive heart failure in five, peripheral vascular disorders in three, and cerebrovascular events in three patients. The patients with CVD (Group 1) were significantly male, older, and had higher BMI (p = 0.027, p < 0.001, and p = 0.041). Obesity (33.4%) and hypertension (27.2%) were the two CV risk factors most frequently. Male sex (HR = 7.818, 95% CI 3.030-20.173, p < 0.001) and hypertension (HR = 4.570, 95% CI 1.567-13.328, p = 0.005) were the independent risk factors for CVD. The prevalence of CVD in RA patients was 4.6%. Some common risk factors for CVD in the general population, including male sex, older age, and hypertension, were evident in RA patients. Male sex and hypertension were the independent risk factors for developing CVD in patients with RA.
dc.identifier.doi10.1007/s00296-023-05515-y
dc.identifier.endpage301
dc.identifier.issn0172-8172
dc.identifier.issue2
dc.identifier.scopus2-s2.0-85180894310
dc.identifier.startpage291
dc.identifier.urihttps://doi.org/10.1007/s00296-023-05515-y
dc.identifier.urihttps://hdl.handle.net/11452/48690
dc.identifier.volume44
dc.identifier.wos001132625000001
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherSpringer Heidelberg
dc.relation.journalRheumatology International
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectTurkish version
dc.subjectScore
dc.subjectReliability
dc.subjectAdaptation
dc.subjectValidity
dc.subjectImpact
dc.subjectRheumatoid arthritis
dc.subjectComorbidity
dc.subjectMajor adverse cardiac events
dc.subjectCardiovascular risk
dc.subjectSecondary disease prevention
dc.subjectPrevalence
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectRheumatology
dc.titlePrevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: A real-life evidence from biostar nationwide registry
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Fizik Tedavi ve Rehabilitasyon Ana Bilim Dalı
local.indexed.atWOS
local.indexed.atScopus
relation.isAuthorOfPublication2aba29a4-d7c1-443c-8dec-31e291a1e5a8
relation.isAuthorOfPublication.latestForDiscovery2aba29a4-d7c1-443c-8dec-31e291a1e5a8

Dosyalar